Publications

Detailed Information

Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study

DC Field Value Language
dc.contributor.authorSong, Sanghyuk-
dc.contributor.authorWu, Hong-Gyun-
dc.contributor.authorLee, Chang Geol-
dc.contributor.authorKeum, Ki Chang-
dc.contributor.authorKim, Mi Sun-
dc.contributor.authorAhn, Yong Chan-
dc.contributor.authorOh, Dongryul-
dc.contributor.authorPark, Hyo Jung-
dc.contributor.authorLee, Sang-Wook-
dc.contributor.authorPark, Geumju-
dc.contributor.authorMoon, Sung Ho-
dc.contributor.authorCho, Kwan Ho-
dc.contributor.authorKim, Yeon-Sil-
dc.contributor.authorWon, Yongkyun-
dc.contributor.authorOh, Young-Taek-
dc.contributor.authorKim, Won-Taek-
dc.contributor.authorJeong, Jae-Uk-
dc.date.accessioned2017-11-02T01:05:02Z-
dc.date.available2017-11-02T10:06:06Z-
dc.date.issued2017-08-30-
dc.identifier.citationBMC Cancer, 17(1):598ko_KR
dc.identifier.issn1471-2407-
dc.identifier.urihttps://hdl.handle.net/10371/138281-
dc.descriptionThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.ko_KR
dc.description.abstractAbstract

Background
Treatment of tonsil cancer, a subset of oropahryngeal cancer, varies between surgery and radiotherapy. Well-designed studies in tonsil cancer have been rare and it is still controversial which treatment is optimal. This study aimed to assess the outcome and failure patterns in tonsil cancer patients treated with either approaches.

Methods
We retrospectively reviewed medical records of 586 patients with tonsil cancer, treated between 1998 and 2010 at 16 hospitals in Korea. Two hundred and one patients received radiotherapy and chemotherapy (CRT), while 385 patients received surgery followed by radiotherapy and/or chemotherapy (SRT). Compared with the SRT group, patients receiving CRT were older, with more advanced T stage and received higher radiotherapy dose given by intensity modulation techniques. Overall survival (OS), disease-free survival (DFS), locoregional recurrence-free survival (LRRFS), distant metastasis-free survival (DMFS), and clinicopathologic factors were analyzed.

Results
At follow-up, the 5-year OS, DFS, LRRFS and DMFS rates in the CRT group were 82, 78, 89, and 94%, respectively, and in the SRT group were 81, 73, 87, and 89%, respectively. Old age, current smoking, poor performance status, advanced T stage, nodal involvement, and induction chemotherapy were associated with poor OS. Induction chemotherapy had a negative prognostic impact on OS in both treatment groups (p=0.001 and p=0.033 in the CRT and SRT groups, respectively).

Conclusions
In our multicenter, retrospective study of tonsil cancer patients, the combined use of radiotherapy and chemotherapy resulted in comparable oncologic outcome to surgery followed by postoperative radiotherapy, despite higher-risk patients having been treated with the definitive radiotherapy. Induction chemotherapy approaches combined with either surgery or definitive radiotherapy were associated with unfavorable outcomes.
ko_KR
dc.description.sponsorshipThis research was supported by a grant from the National Research Foundation of Korea (NRF), which is funded by the Korean government (MEST, grant no.2015M2A2A7055063); a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (H14C3459); and the National R&D Program through the Dong-nam Institute of Radiological and Medical Sciences (DIRAMS) funded by the Ministry of Education, Science, and Technology (50595–2016). The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.ko_KR
dc.language.isoenko_KR
dc.publisherBioMed Centralko_KR
dc.subjectTonsil cancerko_KR
dc.subjectChemoradiotherapyko_KR
dc.subjectSurgeryko_KR
dc.subjectAdjuvant radiotherapyko_KR
dc.subjectInduction chemotherapyko_KR
dc.titleChemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) studyko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor송상혁-
dc.contributor.AlternativeAuthor우홍균-
dc.contributor.AlternativeAuthor이창걸-
dc.contributor.AlternativeAuthor금기창-
dc.contributor.AlternativeAuthor김미선-
dc.contributor.AlternativeAuthor안용찬-
dc.contributor.AlternativeAuthor오동률-
dc.contributor.AlternativeAuthor박금주-
dc.contributor.AlternativeAuthor문성호-
dc.contributor.AlternativeAuthor조관호-
dc.contributor.AlternativeAuthor김연실-
dc.contributor.AlternativeAuthor원용균-
dc.contributor.AlternativeAuthor오영택-
dc.contributor.AlternativeAuthor김원택-
dc.contributor.AlternativeAuthor정재욱-
dc.identifier.doi10.1186/s12885-017-3571-3-
dc.language.rfc3066en-
dc.rights.holderThe Author(s).-
dc.date.updated2017-10-03T16:48:16Z-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share